Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Gistrup
Clinical trial register · Denmark

Clinical Trials in Gistrup, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2469 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:17 UTC
2469
Studies in scope
all four open statuses
1395
Recruiting now
open to new participants
438
Lead sponsors
across recruiting studies
Top sites
Copenhagen 974 Aarhus 586 Odense 441 Aalborg 384 Herlev 314
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Aalborg University14 AstraZeneca6 Novo Nordisk A/S5 Aalborg University Hospital3 Eli Lilly and Company3
Site location
Copenhagen974 Aarhus586 Odense441 Aalborg384 Herlev314
All 128 locations
Target enrolment
to

Trials with a site in Gistrup

43 of 2469 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Not yet open
Comparing Standard Care Approaches for Greater Trochanteric Pain Syndrome in General Practice
NCT07848971Greater Trochanteric Pain Syndrome, Gluteal Tendinopathy, Lateral Hip Pain
Malene Kjær Bruun
Not applicable
192
Gistrup, København NV
2026-09
Active, closed
Quality of Life After Transcatheter Aortic Valve Implantation
NCT07798713Aortic Stenosis, Heart Failure, Angina Pectoris, TAVI(Transcatheter Aortic Valve Implantation)
Aalborg University Hospital
Observational
200
Gistrup
2026-08-26
Not yet open
Aalborg University
Not applicable
4
Gistrup
2026-08-01
Recruiting
AstraZeneca
Phase 3
900
Aarhus N, Gistrup, Herlev, Hillerød, Holbæk, Hvidovre
2026-07-06
Recruiting
Cannabidiol for Pain Relief of Patients With End-stage mCRPC
NCT07549256Metastatic Castration Resistant Prostate Cancer (mCRPC)
DrugCannabidiol
Regionshospital Nordjylland
Phase 2
58
Gistrup
2026-06-12
By invitation
ThyMoves: Screening and Exercise to Improve Muscle, Enhance Quality of Life, and Reduce Fall Risk in Thyroid Disease
NCT06960005Thyroid Disease, Hashimoto's Thyroiditis, Hyperthyreosis and Goiter, Hypothyroidism
Aalborg University Hospital
Not applicable
148
Gistrup
2026-05-15
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Aarhus N, Copenhagen, Esbjerg, Gistrup, Herlev, Roskilde, Viborg
2026-05-11
Recruiting
Aalborg University Hospital
Observational
10
Gistrup
2026-05-08
Not yet open
Aalborg University
Not applicable
30
Gistrup
2026-05-01
Recruiting
Network Effects of Left M1 rTMS: A TMS-EEG Study
NCT07580989Cortical Plasticity
Aalborg University
Not applicable
20
Gistrup
2026-05-01
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Aarhus C, Esbjerg, Gistrup, Herlev, Hilleroed, Hvidovre, København NV, Odense C
2026-04-21
Recruiting
Aalborg University
Not applicable
90
Gistrup
2026-03-01
Recruiting
Novo Nordisk A/S
Phase 3
1,150
Vejle, Gandrup, Gistrup, Hellerup, Hillerød, Hvidovre
2026-02-24
Recruiting
AstraZeneca
Phase 2
124
Aarhus N, Gistrup, Hvidovre
2026-02-10
Not yet open
Aalborg University
Not applicable
210
Gistrup
2026-01-25
Recruiting
Novo Nordisk A/S
Phase 3
332
Gistrup, København Ø
2025-12-18
Recruiting
AstraZeneca
Phase 2
230
Aarhus N, Gistrup, Hvidovre, København Ø, Odense C
2025-12-10
Not yet open
Aalborg University
Not applicable
30
Gistrup
2025-12-01
Recruiting
Eli Lilly and Company
Phase 2
252
Copenhagen, Gistrup, Odense
2025-11-10
Recruiting
Aalborg University
Not applicable
30
Gistrup
2025-11-03
Recruiting
Aalborg University
Not applicable
30
Gistrup
2025-09-17
Recruiting
Bristol-Myers Squibb
Phase 3
450
Gistrup, Glostrup Municipality
2025-07-18
Recruiting
Pfizer
Phase 3
300
Copenhagen, Aarhus, Odense, Gistrup
2025-07-14
Recruiting
Eli Lilly and Company
Phase 3
350
Aarhus, Copenhagen, Gistrup, Odense, Vejle
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
290
Aarhus, Copenhagen, Gistrup, Odense, Vejle
2025-06-26
Recruiting
AstraZeneca
Phase 3
15,100
Aarhus N, Copenhagen, Esbjerg, Frederiksberg, Gandrup, Gistrup, Herlev, Herning
2025-06-04
Active, closed
Aalborg University
Not applicable
26
Gistrup
2025-05-15
Active, closed
Aalborg University
Not applicable
30
Gistrup
2025-05-15
Recruiting
Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study
NCT06906081Cardiovascular Autonomic Neuropathy, Type 2 Diabetes, Diabetic Neuropathies
DrugKerendia
Peter Rossing
Phase 2
100
Gistrup, Herlev
2025-05-02
Recruiting
Aalborg University
Not applicable
90
Gistrup
2025-04-01
Recruiting
AstraZeneca
Phase 3
11,300
Aarhus, Aarhus N, Copenhagen, Esbjerg, Frederiksberg, Gistrup, Herlev, Herning
2025-03-14
Not yet open
Aalborg University
Not applicable
60
Gistrup
2025-03-01
Recruiting
Aalborg University
Not applicable
20
Gistrup, Aalborg
2025-01-06
Recruiting
Pfizer
Phase 3
2,330
Copenhagen, Hilleroed, Herning, Roskilde, Gistrup
2024-12-08
Recruiting
Aalborg University
Not applicable
30
Gistrup
2024-10-01
Active, closed
Novo Nordisk A/S
Phase 4
500
Aarhus, Gistrup, Holbæk
2024-09-17
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Hellerup, Aalborg, Aarhus N, Gistrup, Hillerød, København Ø, Odense C, Svendborg
2024-06-25
Recruiting
Takeda
Phase 2
268
Odense, Esbjerg, Gistrup, Hillerød, Hvidovre, Køge
2024-03-05
Recruiting
Research Unit for General Practice in Aalborg
Phase 4
600
Gistrup
2023-11-13
Active, closed
Novo Nordisk A/S
Phase 3
212
Aarhus, Gistrup, Holbæk
2023-07-07
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Aarhus, Copenhagen NV, Gistrup, Glostrup Municipality, Herlev, Herning
2023-02-15
Active, closed
AstraZeneca
Phase 3
368
Gistrup, Køge, Odense
2022-11-10
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Aarhus, Esbjerg, Gistrup, Hellerup, Herning, Odense, Roskilde, Svendborg
2021-08-14
Rows per page Showing 1–43 of 43
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-denmark/city/gistrup

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,469 studies in total at the last sync on 16 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 43 of those studies with a site in Gistrup.

How many clinical trials are recruiting in Gistrup?

26 of the 43 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:17 UTC sync. A further 6 have not yet opened recruitment, 9 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Gistrup), 43 studies
PhaseStudiesRecruitingShare
Phase 3171139.5%
Not applicable16737.2%
Phase 26614%
Observational214.7%
Phase 4214.7%

Most active sponsors

Lead sponsors with the most studies (Gistrup)
Lead sponsorStudiesRecruiting
Aalborg University147
AstraZeneca65
Novo Nordisk A/S52
Aalborg University Hospital31
Eli Lilly and Company33
Janssen Research & Development, LLC21
Pfizer22
Bristol-Myers Squibb11
Malene Kjær Bruun10
Novartis Pharmaceuticals10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.